
Pfizer PFE
$ 27.22
0.11%
Annual report 2025
added 02-26-2026
Pfizer Total Inventories 2011-2026 | PFE
Annual Total Inventories Pfizer
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.7 B | 10.9 B | 10.2 B | 8.98 B | 9.06 B | 8.05 B | 8.28 B | 7.51 B | 7.58 B | 6.78 B | 7.51 B | 5.66 B | 6.17 B | 7.06 B | 7.77 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.9 B | 5.66 B | 8.14 B |
Quarterly Total Inventories Pfizer
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.5 B | 11.7 B | 10.9 B | 11.7 B | 11.4 B | 10.9 B | 10.2 B | 10.3 B | 9.54 B | 8.98 B | 9.51 B | 10.5 B | 9.98 B | 9.06 B | 8.64 B | 8.95 B | 8.49 B | 8.02 B | 8.05 B | 8.05 B | 8.05 B | 7.07 B | 8.28 B | 8.28 B | 8.28 B | 7.51 B | 7.51 B | 7.51 B | 7.51 B | 7.58 B | 7.58 B | 7.58 B | 7.58 B | 6.78 B | 6.78 B | 6.78 B | 6.78 B | 7.51 B | 7.51 B | 7.51 B | 7.51 B | 5.66 B | 5.66 B | 5.66 B | 5.66 B | 6.17 B | 6.17 B | 6.17 B | 6.17 B | 6.08 B | 6.08 B | 6.08 B | 7.06 B | 6.61 B | 6.61 B | 6.61 B | 6.97 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 11.7 B | 5.66 B | 7.95 B |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alnylam Pharmaceuticals
ALNY
|
82.7 M | $ 320.13 | -3.98 % | $ 41.9 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
177 M | $ 21.81 | 0.6 % | $ 1.02 B | ||
|
Akebia Therapeutics
AKBA
|
15.6 M | $ 1.35 | -12.9 % | $ 347 M | ||
|
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.26 | 0.47 % | $ 456 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 24.19 | -1.59 % | $ 3.08 B | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.61 | 8.05 % | $ 428 M | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
22.9 M | - | - | $ 546 M | ||
|
BioXcel Therapeutics
BTAI
|
722 K | $ 1.07 | 1.9 % | $ 13.1 M | ||
|
ChromaDex Corporation
CDXC
|
14.5 M | - | -0.88 % | $ 598 M |